GLYC
Closed
Glycomimetics Inc
14.62
+14.46 (+9210.19%)
Last Update: 18 Jun 2025 16:30:00
Yesterday: 0.157
Day's Range: 11.06 - 15.81
Send
sign up or login to leave a comment!
When Written:
1.26
GlycoMimetics Inc. is a clinical-stage biotechnology company that is focused on discovering and developing novel small-molecule drugs that mimic the activity of carbohydrates, which are essential components of many biological processes. The company's lead product candidate, uproleselan, is being developed for the treatment of acute myeloid leukemia (AML) and other hematologic malignancies. GlycoMimetics is also developing several other product candidates for the treatment of cancer, sickle cell disease, and other indications. The company was founded in 2003 and is headquartered in Rockville, Maryland.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








